Bing Xu

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology

Yangqiu Li, Yingyong Hou, Ying Cheng, 2019, Cancer biology & medicine.

MEOX2 serves as a novel biomarker associated with macrophage infiltration in oesophageal squamous cell carcinoma and other digestive system carcinomas

Zhi-Hua Zhu, P. Lin, B. Luo, 2021, Autoimmunity.

The role of Central nervous system (CNS) prophylaxis in preventing DLBCL patients from CNS relapse: a network meta-analysis.

Zhijuan Lin, Hanyan Zeng, Zhifeng Li, 2021, Critical reviews in oncology/hematology.

Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments.

Yi-long Wu, Jin-Ji Yang, Xue-Ning Yang, 2021, European journal of cancer.

Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets.

Yi-long Wu, Jin-Ji Yang, Jie Huang, 2021, Clinical lung cancer.

Predictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients

Xiǎohóng Shí, Q. Qu, J. Qu, 2017, Scientific Reports.

First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial

Yangqiu Li, Jin-Ji Yang, Chongrui Xu, 2023, Nature Network Boston.

Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial

Yi-long Wu, Jin-Ji Yang, Chongrui Xu, 2023, EClinicalMedicine.